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Available online 3 August 2016Objective: The aim of our study was to deﬁne predictors of cardiac compression development including clinical,
electrocardiographic, echocardiographic, chest-X-ray and perioperative parameters and their diagnostic value.
Methods: Overall 243 patients with pericardial disease, among them 123 with compression (tamponade,
constriction) and 120 without signs of compression were included in the study. Clinical, laboratory, electrocar-
diographic, chest-X-Ray, echocardiographic and perioperative data were included in the logistic regression
analysis to deﬁne predictors of tamponade/constriction development.
Results: Logistic regression analysis demonstrated large effusion (N20 mm) (OR 5.393, 95%CI 1.202–24.199, p =
0.028), cardiac chamber collapse (OR 31.426, 95%CI 1.609–613-914, p = 0.023) and NYHA class N 3 (OR 8.671,
95%CI 1.730–43.451, p = 0.009) were multivariable predictors of compression development. The model includ-
ing these three variables allowed predicting compression in 91.7% of cases.
ROC analyses demonstrated that all three variables had signiﬁcant diagnostic value with sensitivity of 75.6% and
speciﬁcity of 74.2% for large effusion, low sensitivity and high speciﬁcity for cardiac chamber collapse (35% and
92%) and NYHA class (32.5% and 94.2%).
Conclusion: The independent predictors of compression development are presence of large effusion N20 mm,
cardiac chamber collapse and high NYHA class. The model including all three parameters allows correctly
predicting compression in 91.4% of cases. The diagnostic accuracy of each parameter is characterized by high sen-
sitivity and speciﬁcity of large effusion, high speciﬁcity of cardiac chamber collapse and NYHA class.
© 2016TheAuthors. Publishedby Elsevier Ireland Ltd. This is an open access articleunder the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Tamponade and constrictive pericarditis (CP) are complications
of pericardial diseases (PD), causing heart compression and
accompanied by perioperativemortality in 4–14%of cases [1–5]. Several
studies [2,4–8] reported that in patients with CP referred for
pericardiectomy along with tuberculosis as the main etiological cause,
there is an increase of idiopathic, postradiotherapy pericarditis and
postpericardiotomy syndrome (PPTS). Therefore, early detection of
compression and risk stratiﬁcation seems to be important in prevention
of constriction and tamponade.rgan Transplantation, Bishkek
rdiev).
eliability and freedom from bias
and Ltd. This is an open access articleClinical tamponade signs like jugular vein distention, hepatomegaly,
hypotension and paradoxical pulse, might not be evident in cases of
localized effusion or low-pressure tamponade [1,9,10]. Several studies
also demonstrated, that clinical signs were not suspected in N50% of
cases with echocardiographic (echo) and cardiac catheterization signs
of tamponade [11,12].
Imaging methods allow accurately diagnose tamponade and
constriction, though several parameters need to be combined to identify
correctly compression, as they differ by accuracy and some signs can ac-
company other structural heart diseases [13–15,18].
However, studies on predictors of tamponade and constriction
development in PD are limited and few is knownon factors determining
development of compression. It is known that risk of tamponade in-
creases three-fold when paradoxical pulse exceeds 10 mmHg [19],
and in presence of low voltage QRS, accompanying large effusion [20].
Chronic large effusion might progress to tamponade in about 1/3 of
cases, while in subacute large effusions risk of tamponade is high in
cases unresponsive to medical treatment [13,21,22]. Constrictionunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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despite full resolution of effusion after pericardiocentesis and in
cases of acute pericarditis resistant to treatment with acetylsalicylic
acid [6,23].
It was demonstrated that cardiac chamber collapse (CCol) and infe-
rior vena cava (IVC) plethora lacked value in prediction of tamponade,
while large pericardial effusion increased risk 78-fold [24]. Large effu-
sion size (N500 ml) was shown to predict tamponade development
with accuracy of 100% [25]. It should be also noted, that CCol could be
observed in 1/3 of cases without clinical signs of tamponade [26].
Thus, evidence on factors predictive for development of compres-
sion in PD is limited, few is known whether combination of clinical,
hemodynamic, X-Ray, ECG, and echo parameters may improve early
identiﬁcation of patients at risk of constriction and tamponade.
The aim of our studywas to deﬁnepredictors of cardiac compression
development including clinical, electrocardiographic (ECG), echo,
chest-X-ray and perioperative parameters and their diagnostic value.
2. Methods
We retrospectively analyzed records included in the prospective
database of patients with PD admitted to the Scientiﬁc Research Insti-
tute of Heart Surgery and Organ Transplantation between 1997 and
2014.
2.1. Patients
Overall, 243 consecutive patients with PD referred for treatment in
our center, were included in the study. All patients were divided into
2 groups according to presence of tamponade and constriction signs
[1]: 123 patients with syndrome of compression and 120 patients with-
out signs of compression.
2.2. Clinical variables
The following demographic and clinical data were included in the
analysis: age, gender, etiology of PD, NYHA class, duration of hospitali-
zation; presence of inﬂammation, laboratory analysis; hemodynamic
status— heart rate (HR), systolic (SBP) and diastolic (DBP) blood pres-
sure, central venous pressure (CVP) where appropriate; cardiothoracic
index (CTI), presence of pleural effusion and superior vena cava (SVC)
dilatation/compression on chest X-Ray.
2.3. Echocardiography
Cardiac chambers` size and pericardial involvement (thickening,
calciﬁcation, effusion size, tamponade and constriction signs)were esti-
mated according to recommendations of American Society of Echocar-
diography and European Association of Cardiovascular Imaging [27,28]
using transthoracic 2-dimensional (2D), 2D-guided M-mode and
Doppler echocardiography (echo). The following echo datawere includ-
ed in analysis: left atrial (LA) size, right atrial (RA) enlargement, left
ventricular (LV) end-systolic and end-diastolic dimensions, LV ejection
fraction (LVEF, estimated by Simpson rule), RV dimension, mean
pulmonary arterial pressure, signs of LA, RA, RV and LV collapse
[29–31], IVC plethora [14], respiratory variations of tricuspid andmitral
ﬂows` [32], interventricular septal (IVS) and inter-atrial septal paradox-
ical movement, ﬂat atrioventricular (AV) groove [16], constrictive E/a
pattern ofmitral ﬂow [15,17,33], hepatic vein dilatation and ﬂow rever-
sal [15], and presence of ﬁbrin detachments in pericardial cavity. We
also measured presence and extent of pericardial thickening and
calciﬁcation, extent and size of effusion. Based on above-mentioned
echo data, pericardial compression was deﬁned as tamponade and
constriction [13,15,27–34].2.4. Electrocardiography
ECGs were scanned and digitally analyzed as described previously
[35] for presence of PR segment depression, low voltage QRS, QRS
alternans, ST junction elevation/depression, and P-wave morphology
abnormalities (notched P-wave, changes in amplitude — P mitrale and
pulmonale patterns) [20,36,37]. Arrhythmias and conduction defects
[38] were evaluated from ECGs, and whenever available Holter moni-
toring and telemetry records.
2.5. Pericardiocentesis and pericardiectomy
Pericardiocentesis with and without drainage, subxiphoid
pericardiostomy and pericardiectomy were performed by standard
technique [1,9,39,40]. During interventions and surgery, we assessed
size of effusion obtained by drainage and intraoperatively, and its
extent; during surgery we also evaluated extent and size of adhesions
and calciﬁcations.
2.6. Deﬁnitions
Based on above-mentioned data, pericardial involvementwas classi-
ﬁed as effusion, effusion with compression (tamponade), constriction
and constriction with effusion, adhesive, adhesive with effusion and
adhesive-effusive with signs of compression, as well presence or
absence of compression (tamponade or constriction).
Extent and size of pericardial effusion, thickening and calciﬁcation
of pericardium were classiﬁed based on echo and drainage (effusion)/
intraoperative data. Effusions were categorized by extent as localized
and diffuse; and by size as small (b100ml by drainage/intraoperatively,
b10mm by echo for diffuse effusion and b5 mm for localized effusion),
moderate (100–400 ml by drainage/intraoperatively, 10–20 mm by
echo for diffuse effusion and b5–10 mm for localized effusion), and
large (N400 ml drainage, N20 mm by echo for diffuse effusion and
N10 mm for localized effusion), [1,34,41,42]. Pericardial thickening
and calciﬁcations were graded as localized and diffuse.
Presence of inﬂammation was judged on increased levels of C-
reactive protein (CRP), sedimentation rate, and immune markers
where applicable.
2.7. Outcomes
Outcomeswere recorded based on hospital records and follow-up of
patients. The following outcomes were included in the analysis: recur-
rent PD, heart failure, death and composite outcome.
2.8. Statistical analysis
Statistical analyses were performed using SPSS for Windows
software (IBM, New York). Categorical variables are presented as num-
ber (percentage) and continuous variables asmean (SD). The normality
of data distribution was assessed by Kolmogorov–Smirnov test. Com-
parisons between groups were performed using Chi-square test for
categorical variables and unpaired t test for independent samples for
normally distributed data and Mann–Whitney U test for abnormally
distributed data. Logistic regression analysis (LRA) was performed to
identify predictors of compression syndrome. The dependent variable
was binary-presence or absence of cardiac compression; for selection
of independent variables — variables with signiﬁcance value b 0.1 on
univariate analysis were included in the model. p value b 0.05 was
accepted as a signiﬁcant value for all tests. Diagnostic value of multivar-
iable predictors of cardiac compression was deﬁned using ROC analysis
with assessment of area under the curve (AUC), 95% CI, p values, sensi-
tivity and speciﬁcity.
77T. Kudaiberdiev et al. / IJC Heart & Vasculature 12 (2016) 75–813. Results
3.1. Clinical characteristics, chest X-ray and ECG (Table 1)
As can be seen from Table 1, patients' groups did not differ by age
and duration of hospitalization. There were signiﬁcantly more males
(p = 0.004); patients with neoplastic, infectious PD, heart failure and
trauma (p b 0.0001), high NYHA class, high CVP, tachycardia, low SBP
and high CRP values (p b 0.0001, p = 0.001, p = 0.007, p = 0.001,
and p = 0.04, respectively) in group of compression as compared to
control group.
Chest X-ray showed higher proportion of patients with pleural effu-
sion and dilatation/compression of SVC (p b 0.0001 for both) in group of
compression, though groups did not differ by CTI.Table 1
Clinical, chest X-ray and electrocardiographic characteristics of PD.
Variables Compression +
(n = 123)
Compression−
(n = 120)
p
Age, yearsa 43.42 (17.92) 44.12 (16.74) 0.75
Sex, n(%)
Female 49 (39.8) 70(58.3) 0.004
Male 74(60.2) 50(41.7)
Etiology, n(%)
Neoplastic 20(16.3) 5(4.2) b0.0001
Idiopathic 34(27.6) 31(25.8)
Infectious 35(28.5) 24(20)
Immune 2(1.6) 12(10)
Heart failure 16(13) 5(4.2)
Metabolic 4(3.3) 1(0.8)
Trauma 4(3.3) –
Postpericardiotomy syndrome 7(5.7) 42(35)
Pericardial tumor 1(0.8) –
NYHA classa 3.27 (0.56) 2.63(0.61) b0.0001
Duration of hospitalizationa 13.42 (10.14) 14.52(8.91) 0.38
CVP, mma 168.07(77.84) 84.62(32.56) 0.001
HR, beats/mina 94.18(17.95) 86.07(20.33) 0.001
SBP, mmHga 108.25(18.14) 115.48(21.63) 0.007
DBP, mmHga 68.82(12.84) 71.30(14.00) 0.16
C-reactive protein, mg/dLa 27.35(50.68) 5.37(3.34) 0.04
Hemoglobin, mg/dLa 121.68(20.21) 124.13(22.99) 0.39
Red blood cells, ×1012a 4.07(0.67) 4.25(0.68) 0.04
SR, mm/ha 18.52(16.76) 17.58(15.27) 0.66
Chest X-ray
CTI,%a 59.31(11.11) 60.70(9.19) 0.54
Pleural effusion, n(%) 63(54.8) 33(28.9) b0.0001
Superior vena cava, n(%)
Dilatation 33(26.8) 2(1.7) b0.0001
Compression 8(6.5) 0(0)
Electrocardiography
P “pulmonale” pattern n(%) 9(17.6) 3(5.7) 0.026
Notched P wave, n(%) 26(47.3) 10(24.4) 0.032
PR segment depression, n(%) 34(60.7) 3(7.1) b0.0001
STj elevation, n(%) 26(49.1) 14(26.4) 0.027
STj depression, n(%) 10(28.6) 2(6.5) 0.026
Low voltage QRS, n(%) 59(57.8) 17(20.0) b0.0001
QRS alternans, n(%) 6(6.0) 0(0) 0.032
Arrhythmias and conduction disturbances, n(%)
Sinus tachycardia N 100 beats/min 45(36.5) 21(17.5) 0.013
Sinus bradycardia b 60 beats/min 1(0.8) 6(5.0)
SVT 4(3.2) 1(0.8)
AF/Atrial ﬂutter 14(11.38) 29(24.1)
Sinoatrial block 2(1.6) 1(0.8)
AV block (I and II degree) 3(2.4) 1(0.8)
BBB 3(2.4) 3(2.5)
AF — atrial ﬁbrillation, AV — atrioventricular, BBB — bundle branch block, CVP — central
venous pressure, DBP — diastolic blood pressure, HR — heart rate, SBP — systolic blood
pressure, SR — sedimentation rate, SVT — supraventricular tachycardia.
a Continuous variables presented as mean(SD).ECG analysis revealed association of compressionwith high frequen-
cy of P “pulmonale” pattern and notched P wave (p = 0.026 and p =
0.032), PR-segment depression (p b 0.0001), STj elevation or depression
(p = 0.027 and p = 0.026, respectively), low voltage QRS and QRS
alternans (p b 0.0001 and p= 0.032). Arrhythmias and conduction dis-
turbances more often accompanied compression (p = 0.01), with high
occurrence of sinus tachycardia.
3.2. Echocardiographic data
Analysis of echo data (Table 2) showed no differences between
groups in cardiac chambers' size and mean pulmonary arterial pressure
(p N 0.05). Patients with compression had low LVEF (p = 0.027); more
often RA dilatation (p = 0.014), larger effusion amount (p b 0.0001);
high proportion of large localized and diffuse effusions (p b 0.0001,
p b 0.0001, p = 0.004), diffuse pericardial thickening and diffuse
pericardial calciﬁcation (p b 0.0001 for both), and ﬁbrin detachments
(p b 0.0001) as compared to those without compression. CompressionTable 2
Echocardiographic data.
Variables Compression +
(n = 123)
Compression−
(n = 120)
p
LA, mm 33.78(8.75) 35.89(10.43) 0.10
LVEDD, mm 45.04(6.98) 46.46(6.45) 0.11
LVESD, mm 28.51(5.74) 28.88(5.71) 0.63
LVEF,% 63.43(9.50) 66.05(8.03) 0.027
RV, mm 20.55(5.40) 19.67(7.00) 0.30
Mean PAP, mmHg 29.92(12.81) 30.31(14.09) 0.85
RA dilatation, n(%) 32(27.6) 16(13.9) 0.014
LA dilatation, n(%) 26(22.8) 41(34.5) 0.06
Effusion extent, n(%)
Localized 15(12.2) 58(48.3) b0.0001
Diffuse 88(71.5) 32(26.7)
Size of localized effusion, n(%)
Small b5 mm 2(5.4) 12(20.7) b0.0001
Moderate 5–9 mm 1(7.7) 35(60.3)
Large ≥10 mm 10(76.9) 11(19)
Size of diffuse effusion, n(%)
Small b10 mm 1(1.2) 0(0) 0.004
Moderate 10–20 mm 3(3.6) 6(24)
Large N20 mm 80 (95.2) 19(76)
Mean pericardial thickening, mm* 1.20(1.85) 0.30(0.30) 0.48
Pericardial thickening, n(%) 60(48.8) 37(30.8) 0.006
Extent of pericardial thickening, n(%)
Localized 16 (13) 34(28.3) b0.0001
Diffuse 44 (35.8) 3(2.5)
Calciﬁcation of pericardium, n(%) 31(25.2) 2(1.7) b0.0001
Extent of pericardial calciﬁcation, n(%)
Localized 12(9.8) 2(1.7) b0.0001
Diffuse 19(15.4) 0(0)
Fibrin detachments, n(%) 46(37.4) 13(10.8) b0.0001
IVS paradoxical movement, n(%) 19(15.4) 1(0.8) b0.0001
IAS paradoxical movement, n(%) 3(2.4) 0(0) 0.247
Flat AV groove 13(10.6) 0(0) b0.0001
IVC plethora, n(%) 37(30.1) 0(0) b0.0001
Cardiac chamber collapse, n(%) 43(35) 1(0.8) b0.0001
Mitral ﬂow respiratory changes, n(%) 88(71.5) 24(20) b0.0001
Tricuspid ﬂow respiratory changes,
n(%)
89(72.4) 17(14.2) b0.0001
Hepatic veins dilatation, n(%) 23(18.7) 1(0.8) b0.0001
Hepatic vein ﬂow reversal, n(%) 19(15.4) 0(0) b0.0001
Constriction, n(%) 44(35.8) 0(0) b0.0001
Tamponade, n(%) 53(43.1) 0(0) b0.0001
AV — atrioventricular, IVC — inferior vena cava, IVS — interventricular septum, IAS —
interatrial septum, LA — left atrium, LVEDD — left ventricular end-diastolic dimension,
LVEF— left ventricular ejection fraction, LVESD— left ventricular end-systolic dimension,
PAP— pulmonary arterial pressure, RA — right atrium, RV — right ventricle.
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CCol, IVC plethora, ﬂat AV groove, respiratory changes in the mitral
and tricuspid ﬂow patterns, reversal of ﬂow in hepatic veins and their
dilatation (p b 0.0001 for all).
3.3. Type of intervention, perioperative data and outcomes (Table 3)
Majority of patients with compression underwent pericardiocentesis
(54.5%) and pericardiectomy (27.6%), while controls receivedmostly
medical therapy (56.7%) (p b 0.0001). Peri-interventional data
demonstrated signiﬁcantly larger mean effusion size with 80.6% of
large effusions (N400 ml) of mostly ﬁbrinous and hemorrhagic na-
ture (p b 0.0001, p = 0.02, p b 0.0001), as well as high proportion
of diffuse adhesions and diffuse calciﬁcations of pericardium
(p b 0.0001, p b 0.0001) in compression group as compared to con-
trol group.Table 3
Types of intervention, perioperative data and outcomes.
Variables Compression +
(n = 123)
Compression−
(n = 120)
p
Types of treatment, n(%)
Medical 11(8.9) 68 (56.7) b0.0001
Pericardiocentesis 67(54.5) 10 (8.3)
Pericardioectomy 34 (27.6) 0(0)
Pericardial intervention along
with other types of cardiac
surgery
8(6.5) 40(33.3)
Subxiphoid pericardiostomy 3(2.4) 2(1.7)
Mean effusion size, ml
(intraop., intervention,
drainage)a
1295.67(1023.53) 290.68(461.94) b0.0001
Effusion size by drainage/intraop., n(%)
Small b100 ml 6(8.3) 1(6.7) 0.02
Moderate 100–400 ml 8(11.1) 6(40)
Large N400 ml 58(80.6) 8(53.3)
Extent of effusion echo/drainage/intraop., n(%)
Small 6(4.9) 12(10) b0.0001
Moderate 5(4.1) 47(39.2)
Large 93(75.6) 31(25.8)
Effusion type, n(%)
Serous 52 (42.3) 85 (70.8) b0.0001
Purulent 9(7.3) 4(3.3)
Hemorrhagic 30(24.4) 4(3.3)
Fibrinous 15(12.2) 7(5.8)
Adhesion and calciﬁcations echo/intraop, n(%)
Adhesions 27(22) 55(45.8) b0.0001
Adhesions and calciﬁcations 35(28.5) 2(1.7)
Extent of adhesions & calciﬁcations echo/intraop, n(%)
Localized 18(14.6) 54(25) b0.00001
Diffuse 44(35.8) 3(2.5)
Type of pericardial involvement, n(%)
Effusive 7(5.7) 66(55) b0.0001
Effusion with compression
(tamponade)
60(48.8) 0(0)
Constriction 22(17.9) 0(0)
Constrictive-effusive 23(18.7) 0(0)
Adhesive 0(0) 26(21.7)
Adhesive-effusive 2(1.6) 28(23.3)
Adhesive-effusive with
compression
9(7.3) 0(0)
Outcomes
Recurrence of PD 16 (13) 9 (7.5) 0.017
Death 23 (18.7) 1 (0.8)
Rehospitalization due to HF 1 (0.8) 0 (0)
Composite outcome n(%) 45 (36.6) 11 (9.2) b0.0001
Echo — echocardiography, HF — heart failure, intraop. — intraoperative, PD — pericardia
disease.
a Continuous variables presented as mean(SD).
Table 4
Predictors of compression in patients with PD: logistic regression analysis.
Variables Univariate Multivariable
Score p OR 95%CI p
Age 0.069 0.792
NYHA class 36.329 b0.0001 8.671 1.730–43.451 0.009
Sex 7.001 0.008
HR 12.217 b0.0001
SBP 2.464 0.117
DBP 0.065 0.799
Active inﬂammation 0.243 0.622
Pleural effusion 15.366 b0.0001
SVC compression 26.981 b0.0001
Effusion 25.599 b0.0001
Large effusion 22.236 b0.0001 5.393 1.202–24.199 0.028
Pericardial thickening 6.741 0.009
Diffuse pericardial
thickening
11.057 0.001
Flat AV groove 8.171 0.004
Paradoxical movement of IAS 2.347 0.126
Paradoxical movement of
IVS
11.736 0.001
Cardiac chamber collapse 26.163 b0.0001 31.426 1.609–613-914 0.023
Tricuspid ﬂow respiratory
changes
46.627 b0.0001
Mitral ﬂow respiratory
changes
39.778 b0.0001
IVC plethora 23.637 b0.0001
Dilatation of hepatic veins 12.656 b0.0001
Hepatic vein ﬂow reversal 9.930 0.002
Low voltage QRS 28.191 b0.0001
Arrhythmias&conduction
disturbances
0.839 0.360
Cox & Snell R Square—0.649 Nagelkerke R Square—0.871.
Predicted 91.7% correct.
AV— atrioventricular, CI— conﬁdence interval, DBP— diastolic bloodpressure, HR— heart
rate, IAS— interatrial septum, IVC— inferior vena cava, IVS— interventricular septum, OR
— odds ratio, PD— pericardial disease, SBP— systolic blood pressure, SVC— superior vena
cava.
*OR, 95%CI and p values selected in bold reﬂect signiﬁcance of association.lOverall, in compression group 47.8% of patients had signs of
tamponade and 17.9%/18.7% patients had constriction/constrictive–
effusive involvement, while in control group patients had predomi-
nantly effusive, adhesive and adhesive/effusive involvement with-
out signs of compression (p b 0.0001).
Analysis of outcomes revealed that 36.6% patients with compression
and 9.2% of patients without compression had developed adverse out-
comes (p b 0.0001). The difference between groups in outcomes was
mostly due to higher mortality rate in patients with compression
(18.7% vs. 0.8%, p = 0.017).
3.4. Predictors of compression syndrome development and diagnostic
accuracy of markers of compression syndrome
Logistic regression analysis (Table 4) demonstrated male sex, NYHA
class, tachycardia, low voltage QRS, presence of pleural effusion, SVC
compression, extent of effusion and extent of pericardial thickening,
paradoxicalmovement of IVS septum, ﬂat AV groove, CCol, IVC plethora,
respiratory changes in mitral and tricuspid ﬂow patterns, and dilatation
of and ﬂow reversal in hepatic veins as univariate predictors of com-
pression in patients with PD. However, only large effusion (N20 mm)
(OR 5.393, 95%CI 1.202–24.199, p = 0.028), CCol (OR 31.426, 95%CI
1.609–613-914, p = 0.023) and NYHA class N 3 (OR 8.671, 95%CI
1.730–43.451, p=0.009)weremultivariable predictors of compression
development. The model including these three variables allowed
predicting compression in 91.7% of cases.
ROC analyses (Fig. 1) demonstrated that all three variables had
signiﬁcant diagnostic value with sensitivity of 75.6% and speciﬁcity of
74.2% for large effusion, low sensitivity and high speciﬁcity for CCol
(35% and 92%) and NYHA class (32.5% and 94.2%).
Fig. 1. Diagnostic value of large effusion, cardiac chamber collapse and NYHA class in prediction of compression: ROC analysis.
AUC 95%CI p Cut-off Sensitivity Speciﬁcity
Large effusion 0.71 0.647-0.782 b0.0001 Large effusion N20mm 75.6% 74.2%
Cardiac chamber collapse 0.67 0.607-0.739 b0.0001 Presence of collapse 35% 92%
NYHA class 0.74 0.687-0.808 b0.0001 NYHA 3 and higher 32.5% 94.2%
AUC – area under the curve, CI – conﬁdence interval, ROC – receiver operator curve
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Our study demonstrated that compression in PD was characterized
by large diffuse effusion and diffuse calciﬁcation associated with
tamponade and constriction physiology, accompanied by severe clinical
manifestations, hemodynamic compromise, high occurrence of pleural
effusion and compression of vena cava; high incidence of arrhythmias,
and high rate of adverse outcomes. We also showed that patients with
NYHA class N 3, signs of large effusion on echo N 20 mm and CCol
were 5.3–31.4 times more likely to develop compression syndrome.
These 3 predictors of tamponade and constriction were independent
of sex, tachycardia, pleural effusion and SVC compression, low voltage
QRS, diffuse thickening and calciﬁcation of pericardium, paradoxical
movement of IVS and ﬂat AV groove, plethora of IVC, constrictive
pattern of mitral ﬂow, respiratory changes of mitral and tricuspid
ﬂows, dilatation of hepatic veins and their ﬂow reversal. Analysis of di-
agnostic accuracy of these parameters showed that presence of large ef-
fusion alone might identify correctly compression in 3/4 of cases,
absence of CCol and absence of NYHA class N 3might allow towithdraw
diagnosis of compression in 92% of cases.
The results on clinical, echo, perioperative features of tamponade
and constriction are in agreement with previous studies [1–3,5,7,9,13,
15]. Our data are also in concordance with previous investigations on
prognostic signiﬁcance of large effusion in pericarditis [24,25], and
pleural effusion in PPTS [43], diagnostic value of low voltage QRS in car-
diac tamponade [20], as well as high diagnostic value of echo signs of
tamponade [13,14] and constriction [15–17] in patients with PD.We extended previous investigations [24–26] demonstrating
combined prognostic value and diagnostic accuracy of large effusion,
CCol and high NYHA class in prediction of tamponade and constriction
development. Though large effusion has been shown to have prognostic
value in development of tamponade, we for the ﬁrst time demonstrated
the diagnostic accuracy of large effusion N20 mm, CCol and NYHA class
in prediction of compression development.
So far, only few studies evaluated the prognostic value of large
effusion, CCol and IVC plethora in prediction of tamponade develop-
ment [24,25]. It has been shown that CCol and IVC plethora had no
prognostic value, while size of pericardial effusion alone or when used
in combinationwith other clinical parameters could predict tamponade
development [24,25]. Eisenberg et al. [24] in a study of 187 patients
with pericardial effusion, among them 6% with large, 21% with
moderate and 73% with small effusion, demonstrated RA collapse in
12% andRV collapse in 7%of patients and IVC plethora in 35% of patients.
During the period of hospitalization 5% developed tamponade signs and
9% had tamponade signs treated by pericardiocentesis or surgery.
Authors demonstrated, that among all above mentioned echo parame-
ters, only effusion size had predictive value for tamponadedevelopment
(OR 78, 95%CI 14–421, p= 0.0001). In a recent study [25] of 44 patients
with uremic pericardial effusion, large effusions N 500mlwere detected
in 30% and tamponade developed in 16% of patients. The predictive
value of large effusion for tamponade and drainage was 100%. In
our study, the predictive value of large effusion (OR 5.3) was
lower than in study by Eisenberg et al. [24] and can be explained by
differences in study population and design, in our study we included
AF atrial ﬁbrillation
AUC area under the curve
AV atrioventricular
BBB bundle branch block
CCol cardiac chamber collapse
CI conﬁdence interval
CP constrictive pericarditis
CRP C-reactive protein
CTI cardio-thoracic index
CVP central venous pressure
DBP diastolic blood pressure
ECG electrocardiogram
echo echocardiography
HF heart failure
HR heart rate
IAS interatrial septum
intraop. intraoperative
IVC inferior vena cava
IVS interventricular septum
LA left atrium
LRA logistic regression analysis
LV left ventricle
LVEDD left ventricular end diastolic dimension
LVEF left ventricular ejection fraction
LVESD left ventricular end systolic dimension
NYHA New York Heart Association
OR odds ratio
PAP pulmonary arterial pressure
PD pericardial disease
PPTS postpericardiotomy syndrome
RA right atrium
ROC receiver operator curve
RV right ventricle
SBP systolic blood pressure
SD standard deviation
SR sedimentation rate
SVC superior vena cava
SVT supraventricular tachycardia
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that in our heterogeneous population large effusion N 20 mm had rea-
sonably high sensitivity of 75.6% and speciﬁcity of 74.2%, meaning
when using this parameter alone compression might be predicted in
3/4 of patients with large effusion, though 1/4 of themmay not develop
compression.
In opposite to previous study [24], we demonstrated that presence
of CCol increased by 31.496-fold risk of compression/tamponade devel-
opmentwith only 8% of patients without compression syndromewould
have tamponade development. It is known that about 1/3 of patients
without tamponade might have any CCol [26]. Merce et al. [26] in a
study of 110 patients with pericardial effusion demonstrated that
among 38 patients with clinical signs of tamponade 90% had CCol,
while in patients without tamponade collapse were registered in 34%
of patents, yielding 90% sensitivity and 65% speciﬁcity for any chamber
collapse. Our study is distinctive by the fact that we demonstrated diag-
nostic value of CCol in prediction of compression development. Based
on our and Merce et al. [26] study results, we can suppose that in
about 1/3 of those patients with effusion and CCol but without
tamponade signs risk of further tamponade development is 31-fold
high.
We also found that our patients with NYHA class N 3 had 8.681-fold
high risk of compression development. Previous studies [2,3,5,7],
demonstratedNYHA class as a predictor of adverse outcomes in patients
with constrictive pericarditis and tamponade, undergoing surgery. High
NYHA class had low sensitivity and high speciﬁcity in our study and it
might have not value when used alone, as it may accompany advanced
structural heart disease.
Overall, results on diagnostic accuracy of 3 predictors of compres-
sion, suggest their complementary diagnostic and predictive value,
model including all three parameters allowed to correctly predict
syndrome of compression in 91.4% of patients with signs of tamponade
and constriction. This relatively simple model will allow to rise suspi-
cion of compression syndrome in patients with PD, evenwithout specif-
ic clinical signs, using bedside echo or in facilities without advanced
diagnostic methods and refer early patients for evaluation and proper
management.
We should also emphasize that multivariable predictors of
compression were only those characteristic for tamponade: CCol
and large effusion, this can be explained by the fact that compression
by tamponade in our patients was due to relatively faster accumula-
tion of effusion as compared to development of thickening and calci-
ﬁcation of pericardium in constriction. We also cannot exclude the
factor of heterogeneity of the patient group with compression,
including majority with effusion/tamponade and only 1/3 with
constriction.5. Study limitations
The potential limitations of the study are the relatively small sample,
retrospective analysis, and inclusion patients with tamponade and
constrictive pericarditis. This requires further study on predictors of
compression syndrome separately in patientswith tamponade and con-
strictive pericarditis.6. Conclusion
The independent predictors of compression development are
presence of large effusion N 20 mm, cardiac chamber collapse and
high NYHA class. The model including all three parameters allows cor-
rectly predicting compression in 91.4% of cases. The diagnostic accuracy
of each parameter is characterized by high sensitivity and speciﬁcity of
large effusion, high speciﬁcity of cardiac chamber collapse and NYHA
class.Conﬂict of interest
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